News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
156 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (22867)
Month
January (2433)
February (2868)
March (3029)
April (3116)
May (3356)
June (2727)
July (2287)
August (2493)
September (558)
Day
1 (32)
2 (100)
3 (113)
4 (139)
5 (216)
6 (51)
8 (27)
9 (93)
10 (156)
11 (131)
12 (218)
13 (41)
15 (20)
16 (35)
17 (163)
18 (190)
19 (161)
20 (51)
22 (31)
23 (149)
24 (237)
25 (172)
26 (275)
27 (67)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
Day
1
2
3
4
5
6
8
9
10
11
12
13
15
16
17
18
19
20
22
23
24
25
26
27
Insights
HER2’s Digital Rebirth Is Unlocking the Full Potential of ADCs
As next-generation antibody-drug conjugates reshape cancer care, digital pathology and artificial intelligence are transforming how HER2 is measured. The advances aim to help clinicians identify low and ultra-low expressors, match patients to the right therapies and make more precise treatment decisions.
February 10, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
February 10, 2026
·
1 min read
Press Releases
LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026
February 10, 2026
·
1 min read
Press Releases
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
February 10, 2026
·
3 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
·
4 min read
Press Releases
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
February 10, 2026
·
2 min read
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 9, 2026
February 10, 2026
·
1 min read
Press Releases
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis on February 10, 2026
February 10, 2026
·
2 min read
Press Releases
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
February 10, 2026
·
4 min read
Press Releases
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
February 10, 2026
·
18 min read
Previous
4 of 16
Next
